Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Interest & Investment Income (2020 - 2025)

Historic Interest & Investment Income for Rhythm Pharmaceuticals (RYTM) over the last 6 years, with Q3 2025 value amounting to $4.3 million.

  • Rhythm Pharmaceuticals' Interest & Investment Income rose 675.88% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.7 million, marking a year-over-year decrease of 194.46%. This contributed to the annual value of $14.7 million for FY2024, which is 549.3% up from last year.
  • As of Q3 2025, Rhythm Pharmaceuticals' Interest & Investment Income stood at $4.3 million, which was up 675.88% from $3.2 million recorded in Q2 2025.
  • In the past 5 years, Rhythm Pharmaceuticals' Interest & Investment Income ranged from a high of $4.3 million in Q3 2025 and a low of $21000.0 during Q2 2021
  • In the last 5 years, Rhythm Pharmaceuticals' Interest & Investment Income had a median value of $3.2 million in 2023 and averaged $2.4 million.
  • As far as peak fluctuations go, Rhythm Pharmaceuticals' Interest & Investment Income plummeted by 9737.83% in 2021, and later skyrocketed by 216940.3% in 2022.
  • Quarter analysis of 5 years shows Rhythm Pharmaceuticals' Interest & Investment Income stood at $134000.0 in 2021, then skyrocketed by 2169.4% to $3.0 million in 2022, then rose by 25.58% to $3.8 million in 2023, then decreased by 7.96% to $3.5 million in 2024, then increased by 23.13% to $4.3 million in 2025.
  • Its Interest & Investment Income was $4.3 million in Q3 2025, compared to $3.2 million in Q2 2025 and $3.6 million in Q1 2025.